The Form 4 filing, a report of an insider's stock trades, was filed on October 13, 2026. It covers sales on October 12, one day earlier. Mecklenburg Gabriel M.I. is listed as a director, executive chairman and co-founder.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-12 |
| Date of Latest Transaction | 2026-10-12 |
| Buy/Sell | sell |
| Transaction Count | 4 |
| Shares Transacted | 200,000 |
| Price | $103.13 |
| Total Transaction Value | $20,626,371.38 |
| Insider | |
| Ticker Symbol | HNGE |
| Company | Hinge Health, Inc. |
| Insider Name | Mecklenburg Gabriel M.I. |
| Insider Title | Director, Other, Exec. Chairman & Co-Founder |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 0 |
| Position Size Change | 100.00% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported under SEC transaction code S. The report covers four sales of Hinge Health (HNGE) stock.
What was the average price of the transaction?
The average price was $103.13 per share. That average covers the 200,000 shares sold across the four transactions. The available details do not show a separate price for each sale.
How did this transaction affect the insider's holdings?
The sales reduced the reported balance by 200,000 shares, leaving zero shares in that balance. The 100.00% figure means all shares in that balance before the sales were sold. The available details do not show whether this balance covers every account or type of company stock. Whether the insider held other company shares remains unknown.
What's the total transaction value?
The total value was $20,626,371.38 for the four sales combined.
Are there any special circumstances around this transaction?
The transaction information includes a Rule 10b5-1 reference, which concerns plans that set trading instructions in advance. The available details do not confirm which of the four sales this reference covers. Footnotes and plan terms are unavailable. Any plan's start date and trading schedule are also unknown.
For research purposes only; not investment advice.